🟢 Oscar Health is trading 4.43% up in pre-market after raising full-year revenue outlook

Oscar Health is trading at $36.75, up 4.43% in pre-market after raising its full-year revenue outlook.

• Q3 revenue was $5.1 billion, diluted EPS was $0.49, and the medical loss ratio was 84.0%.
• The full-year revenue outlook is $19.0–$19.3 billion.
• The earnings call was scheduled for 8:00 a.m. ET on November 5, 2026.